Publication: 3656

Publication: 3656

Comparative Outcomes and Molecular Response Predictors of IDH1/2-mutated Adult Acute Myeloid Leukemia (AML) Patients (Pts) after Frontline Treatment with Intensive Induction Chemotherapy (IC), Targeted Inhibitors, or Hypomethylating Agents (HMA) (Alliance)

DOI

URL

Google Scholar

Citation:: Blood vol 138 (Supplement 1) 226

Meeting Instance:: ASH 2021
Year:: 2021
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: Leuk Corr Sci
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171;

Corr. Author:
Authors:: Uma Borate Prapti Patel Chetasi Talati Jessica Kohlschmidt Michael Ozga Yazan Madanat Luke Fletcher Ravi Patel Krzysztof Mrózek Deedra Nicolet Akriti Jain Virginia Volpe Fei Yang Richard Press Daniel Jones James S. Blachly Andrew J. Carroll Guido Marcucci Maria Baer William G. Blum Bayard L. Powell Jonathan E. Kolitz Richard M. Stone John C. Byrd Alice S. Mims Kendra Sweet Ann-Kathrin Eisfeld

Networks:: CA043, FL065, LAPS-AL002, LAPS-MA036, LAPS-OH007, LAPS-PA015, LAPS-TX011, MD015, NC002, NORTHWELL, OH008, OH070

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-20202, CALGB-8461, CALGB-9665
Phases:: N/A

Keywords: